Literature DB >> 33720991

Genomics of an endemic cystic fibrosis Burkholderia multivorans strain reveals low within-patient evolution but high between-patient diversity.

Cédric Lood1,2, Charlotte Peeters3, Quentin Lamy-Besnier1, Jeroen Wagemans1, Daniel De Vos4, Marijke Proesmans5, Jean-Paul Pirnay4, Fedoua Echahidi6, Denis Piérard6, Matthieu Thimmesch7, Anca Boeras8, Katrien Lagrou9,10, Evelien De Canck3, Elke De Wachter11, Vera van Noort2,12, Rob Lavigne1, Peter Vandamme3.   

Abstract

Burkholderia multivorans is a member of the Burkholderia cepacia complex (Bcc), notorious for its pathogenicity in persons with cystic fibrosis. Epidemiological surveillance suggests that patients predominantly acquire B. multivorans from environmental sources, with rare cases of patient-to-patient transmission. Here we report on the genomic analysis of thirteen isolates from an endemic B. multivorans strain infecting four cystic fibrosis patients treated in different pediatric cystic fibrosis centers in Belgium, with no evidence of cross-infection. All isolates share an identical sequence type (ST-742) but whole genome analysis shows that they exhibit peculiar patterns of genomic diversity between patients. By combining short and long reads sequencing technologies, we highlight key differences in terms of small nucleotide polymorphisms indicative of low rates of adaptive evolution within patient, and well-defined, hundred kbps-long segments of high enrichment in mutations between patients. In addition, we observed large structural genomic variations amongst the isolates which revealed different plasmid contents, active roles for transposase IS3 and IS5 in the deactivation of genes, and mobile prophage elements. Our study shows limited within-patient B. multivorans evolution and high between-patient strain diversity, indicating that an environmental microdiverse reservoir must be present for this endemic strain, in which active diversification is taking place. Furthermore, our analysis also reveals a set of 30 parallel adaptations across multiple patients, indicating that the specific genomic background of a given strain may dictate the route of adaptation within the cystic fibrosis lung.

Entities:  

Year:  2021        PMID: 33720991      PMCID: PMC7993779          DOI: 10.1371/journal.ppat.1009418

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  66 in total

1.  FastTree 2--approximately maximum-likelihood trees for large alignments.

Authors:  Morgan N Price; Paramvir S Dehal; Adam P Arkin
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

Review 2.  Microdiversity shapes the traits, niche space, and biogeography of microbial taxa.

Authors:  Alyse A Larkin; Adam C Martiny
Journal:  Environ Microbiol Rep       Date:  2017-03-13       Impact factor: 3.541

Review 3.  The multifarious, multireplicon Burkholderia cepacia complex.

Authors:  Eshwar Mahenthiralingam; Teresa A Urban; Joanna B Goldberg
Journal:  Nat Rev Microbiol       Date:  2005-02       Impact factor: 60.633

4.  Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.

Authors:  H Revets; P Vandamme; A Van Zeebroeck; K De Boeck; M J Struelens; J Verhaegen; J P Ursi; G Verschraegen; H Franckx; A Malfroot; I Dab; S Lauwers
Journal:  Acta Clin Belg       Date:  1996       Impact factor: 1.264

5.  Temperate phages both mediate and drive adaptive evolution in pathogen biofilms.

Authors:  Emily V Davies; Chloe E James; David Williams; Siobhan O'Brien; Joanne L Fothergill; Sam Haldenby; Steve Paterson; Craig Winstanley; Michael A Brockhurst
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

6.  Bandage: interactive visualization of de novo genome assemblies.

Authors:  Ryan R Wick; Mark B Schultz; Justin Zobel; Kathryn E Holt
Journal:  Bioinformatics       Date:  2015-06-22       Impact factor: 6.937

7.  Roary: rapid large-scale prokaryote pan genome analysis.

Authors:  Andrew J Page; Carla A Cummins; Martin Hunt; Vanessa K Wong; Sandra Reuter; Matthew T G Holden; Maria Fookes; Daniel Falush; Jacqueline A Keane; Julian Parkhill
Journal:  Bioinformatics       Date:  2015-07-20       Impact factor: 6.937

8.  What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics.

Authors:  Jaroslav Nunvar; Vaclav Capek; Karel Fiser; Libor Fila; Pavel Drevinek
Journal:  PLoS Pathog       Date:  2017-12-11       Impact factor: 6.823

9.  IslandViewer 4: expanded prediction of genomic islands for larger-scale datasets.

Authors:  Claire Bertelli; Matthew R Laird; Kelly P Williams; Britney Y Lau; Gemma Hoad; Geoffrey L Winsor; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

View more
  5 in total

1.  SASpector: analysis of missing genomic regions in draft genomes of prokaryotes.

Authors:  Cédric Lood; Alejandro Correa Rojo; Deniz Sinar; Emma Verkinderen; Rob Lavigne; Vera van Noort
Journal:  Bioinformatics       Date:  2022-05-13       Impact factor: 6.931

2.  Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol).

Authors:  Jolien Onsea; Saartje Uyttebroek; Baixing Chen; Jeroen Wagemans; Cédric Lood; Laura Van Gerven; Isabel Spriet; David Devolder; Yves Debaveye; Melissa Depypere; Lieven Dupont; Paul De Munter; Willy E Peetermans; Vera van Noort; Maia Merabishvili; Jean-Paul Pirnay; Rob Lavigne; Willem-Jan Metsemakers
Journal:  Viruses       Date:  2021-08-05       Impact factor: 5.048

Review 3.  Adaptation and Evolution of Pathogens in the Cystic Fibrosis Lung.

Authors:  Paul J Planet
Journal:  J Pediatric Infect Dis Soc       Date:  2022-09-07       Impact factor: 5.235

4.  Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler.

Authors:  Brieuc Van Nieuwenhuyse; Dimitri Van der Linden; Olga Chatzis; Cédric Lood; Jeroen Wagemans; Rob Lavigne; Kaat Schroven; Jan Paeshuyse; Catherine de Magnée; Etienne Sokal; Xavier Stéphenne; Isabelle Scheers; Hector Rodriguez-Villalobos; Sarah Djebara; Maya Merabishvili; Patrick Soentjens; Jean-Paul Pirnay
Journal:  Nat Commun       Date:  2022-09-29       Impact factor: 17.694

5.  Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae.

Authors:  Anaïs Eskenazi; Cédric Lood; Julia Wubbolts; Maya Hites; Nana Balarjishvili; Lika Leshkasheli; Lia Askilashvili; Leila Kvachadze; Vera van Noort; Jeroen Wagemans; Marc Jayankura; Nina Chanishvili; Mark de Boer; Peter Nibbering; Mzia Kutateladze; Rob Lavigne; Maya Merabishvili; Jean-Paul Pirnay
Journal:  Nat Commun       Date:  2022-01-18       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.